Plaque psoriasis typically forms on the scalp, trunk, elbows, and knees. Treating plaque psoriasis will depend on the ...

"I would come out of the shower and still have flakes on my scalp, and was confused because I had just washed my hair." The ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Plaque psoriasis misdiagnosis is common in people of color. Learn the reasons why, how it can affect your health, and what you can do to get better care.

according to the analysis of patients with plaque psoriasis. “We typically don’t think about putting cream on the scalp,” she added, but additional research looking at this PAD-formulated ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis, marking the company’s entry into immuno-dermatology ...

ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis ... based on the PDUFA for the treatment of scalp and body psoriasis, the potential for clinical results for ZORYVE ...

Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...